Literature DB >> 34315315

A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

Simone Warrack1, Terri Love1, William B Rizzo1.   

Abstract

Sjögren-Larsson syndrome (SLS) is a rare neurologic disorder caused by pathogenic sequence variants in ALDH3A2 and characterized by ichthyosis, spasticity, intellectual disability, and a crystalline retinopathy. Neurologic symptoms develop in the first 2 years of life. Except for worsening ambulation due to spastic diplegia and contractures, the neurologic disease has been considered static and a neurodegenerative course is distinctly unusual. We describe a young child with Sjögren-Larsson syndrome who exhibited an early and severely progressive neurologic phenotype that may have been triggered by a febrile rotavirus infection. Together with 7 additional published cases of these atypical patients, we emphasize that a neurodegenerative course can be an extreme outcome for a minority of patients with Sjögren-Larsson syndrome.

Entities:  

Keywords:  ichthyosis; intellectual disability; leukodystrophy; myelin; spasticity

Mesh:

Year:  2021        PMID: 34315315      PMCID: PMC8458237          DOI: 10.1177/08830738211029390

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.

Authors:  Ariana Kariminejad; Mohammadreza Barzgar; Bita Bozorgmehr; Elham Keshavarz; Mohamad Hasan Kariminejad; Dana S'Aulis; William B Rizzo
Journal:  Eur J Med Genet       Date:  2017-11-26       Impact factor: 2.708

2.  Large contiguous gene deletions in Sjögren-Larsson syndrome.

Authors:  Holly Engelstad; Gael Carney; Dana S'aulis; Janae Rise; Warren G Sanger; M Katharine Rudd; Gabriele Richard; Christopher W Carr; Omar A Abdul-Rahman; William B Rizzo
Journal:  Mol Genet Metab       Date:  2011-05-30       Impact factor: 4.797

Review 3.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

4.  Sjögren-Larsson syndrome: physical and neurological features. A survey of 35 patients.

Authors:  S Jagell; J Heijbel
Journal:  Helv Paediatr Acta       Date:  1982

5.  MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.

Authors:  Michèl A A P Willemsen; Marinette Van Der Graaf; Marjo S Van Der Knaap; Arend Heerschap; Peter H M F Van Domburg; Fons J M Gabreëls; Jan J Rotteveel
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

6.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

7.  Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients.

Authors:  V De Laurenzi; G R Rogers; E Tarcsa; G Carney; L Marekov; S J Bale; J G Compton; N Markova; P M Steinert; W B Rizzo
Journal:  J Invest Dermatol       Date:  1997-07       Impact factor: 8.551

8.  Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report.

Authors:  Kye Hee Cho; Sung Han Shim; Youngsoo Jung; Se Ra Sung; MinYoung Kim
Journal:  BMC Med Genet       Date:  2018-08-29       Impact factor: 2.103

9.  Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.

Authors:  Pippa Staps; William B Rizzo; Frédéric M Vaz; Marianna Bugiani; Martin Giera; Bram Heijs; Antoine H C van Kampen; Mia L Pras-Raves; Marjolein Breur; Annemieke Groen; Sacha Ferdinandusse; Marinette van der Graaf; Gert Van Goethem; Martin Lammens; Ron A Wevers; Michèl A A P Willemsen
Journal:  J Inherit Metab Dis       Date:  2020-07-09       Impact factor: 4.982

10.  Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.

Authors:  Pippa Staps; Judith van Gaalen; Peter van Domburg; Peter M Steijlen; Sacha Ferdinandusse; Tom den Heijer; Marieke M B Seyger; Thomas Theelen; Michèl A A P Willemsen
Journal:  JIMD Rep       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.